Adage Capital Partners Gp, L.L.C. Rezolute, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Rezolute, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,525,883 shares of RZLT stock, worth $9.72 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,525,883
Previous 315,845
699.72%
Holding current value
$9.72 Million
Previous $1.53 Million
686.94%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$43.4 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$11 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$10.8 Million2.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$8.94 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.74MShares$6.72 Million0.04% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $149M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...